Test DirectoryTests
p21 WAF1, Inhibitory GeneCategory:Immunohistochemistry markers Test CodeI p21WAF MethodologyImmunohistochemistry
Clone 4D10 p27Kip, Kinase Inhibitory Protein 1 by IHCCategory:Immunohistochemistry markers Test CodeI p27KIP Associationskinase inhibitory protein 1 MethodologyImmunohistochemsitry; clone 1B4 p53 deletion 17p13Category:Oncology Test CodeF P53 AssociationsChronic lymphocytic leukemia (CLL), B-cell prolymphocytic leukemia (PLL), B-cell lymphoproliferative disorder (LPD), Myeloma MethodologyFluorescence in situ Hybridization (FISH) Panhematopoetic Markers by ImmunohistochemistryCategory:Immunohistochemistry groups AssociationsI CD45: CD45 leukocyte common antigen MethodologyImmunohistochemistry Paroxysmal Nocturnal Hemoglobinuria (CD55, CD59, FLAER)Category:Flow Cytometry Test CodeFLOW PNH MethodologyFlow cytometry, multiparameter analysis pERK 1/2, Extracellular Signal Related KinaseCategory:Immunohistochemistry markers Test CodeI PERK1/2 MethodologyImmunohistochemistry
Clone: MAPK-YT Phelan-McDermid Syndrome, deletion 22q13Category:Constitutional Test CodeF PMS MethodologyFluorescence in situ Hybridization (FISH) Plasma Cell Markers by ImmunohistochemistryCategory:Immunohistochemistry groups AssociationsI P63PC: Plasma cell p63
I CD138: CD138 plasma cells, subset epithelial cells
I KAPLAM: Kappa, Lambda Ig light chains double stain
I KAPPA: Kappa immunoglobulin light chains
I LAMBDA: Lambda immunoglobulin light chains MethodologyImmunohistochemistry PML/RARA Quantitative PCR Disease MonitoringCategory:Quantitative PCR for MRD Test CodeP PMLRARAm AssociationsAcute promyelocytic leukemia (APL), FAB M3 MethodologyQuantitative reverse transcriptase polymerase chain reaction (qRT-PCR) for PML/RARA t(15;17) long form OR PML/RARA t(15;17) short form PML/RARA Quantitative PCR Initial Diagnostic WorkupCategory:Acute Myeloid Leukemia (AML) Test CodeP PML RARA AssociationsAcute promyelocytic leukemia (APL), FAB M3 MethodologyQuantitative reverse transcriptase polymerase chain reaction (qRT-PCR) for
PML/RARA t(15;17) long form and PML/RARA t(15;17) short form PML/RARA t(15,17)Category:Acute Myeloid Leukemia (AML) Test CodeF PML/RARA AssociationsAcute promyelocytic leukemia (APL) MethodologyFluorescence in situ Hybridization (FISH) Prader-Willi SyndromeCategory:Constitutional Test CodeF PWS Associationsdeletion 15q11 MethodologyFluorescence in situ Hybridization (FISH) pRb, Phosphorylated Retinoblastoma Suppressor ProteinCategory:Immunohistochemistry markers Test CodeI PRB MethodologyImmunohistochemistry
Clone: EP821Y ProEx™ C Biomarker by ImmunohistochemistryCategory:Immunohistochemistry markers Test CodeI PROEXC or I PROEXC TC AssociationsAberrant S phase MethodologyImmunohistochemistry Prognostic Markers by ImmunohistochemistryCategory:Immunohistochemistry groups AssociationsI CATH D: Cathepsin D, breast carcinoma
I EGFR1: Epidemal growth factor receptor (HER1)
I ERCC1:Excision repair cross complementing polypeptide
I HER2: HER2/neu (IVD)
I MSI: Microsatellite instability - MLH1, MSH2, MSH6
I P53: p53 tumor suppressor g ... MethodologyImmunohistochemistry Proliferation Markers by ImmunohistochemistryCategory:Immunohistochemistry groups AssociationsI AKT----Akt, protein kinase B
I KI67--- Ki67 (MIB-1) cell proliferation marker
I WT1: Wilms tumor MethodologyImmunohistochemistry Prostate Markers by ImmunohistochemistryCategory:Immunohistochemistry groups AssociationsI PIN2: PIN-2 cocktail (P504S, CK HMW)
I PIN4: PIN-4 cocktail (P504S, CK HMW, P63)
I PSA: Prostate specific antigen (PSA)
I PSAP: Prostatic acid phosphorase
I P504S: P504S gene product (AMACR) MethodologyImmunohistochemistry Prostate Specific Antigen, TotalCategory:Tumor Markers Test CodePSA MethodologyChemiluminescent Immunoassay PTEN/CEP10 deletion 10q23.3Category:Breast Cancer Test CodeF PTEN AssociationsBreast cancer, endometrial carcimomas, glioblastoma MethodologyFluorescence in situ Hybridization (FISH) |
Follow MPLNTesting Links
Search Test DirectoryA-Z Test Names
Tests by CategoryFeatured Tests
|